The vast majority of individuals have detectable antibodies up to three months post contracting the SARS-CoV-2 virus the virus that causes COVID-19.
The research noted that people with the COVID-19 virus infection are most likely to be highly infectious from symptom onset and the following five days.
A new study has suggested that taking antidepressant drug fluvoxamine may be effective in preventing severe COVID-19 symptoms and hospitalisation.
If you’re hesitant to get a COVID-19 vaccine you’re not alone. A survey reveals that vaccine hesitancy is increasing among adults across the globe.
New research says that delirium a state of acute mental confusion accompanied by a fever could be an early symptom of COVID-19.
The study revealed that the unique characteristics of the SARS-CoV-2 virus and may explain why patients suffer from 'long COVID'.
There are actually 'seven forms of disease in mild Covid-19' with different groups of symptoms according to a new study.
World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus however added that he was feeling well and did not have any symptoms.
Researchers recommend prompt adoption of isolation measures as soon as a person feels ill to reduce the probability of household transmission of COVID-19.
Some patients with COVID-19 have persistent skin-related symptoms long after their initial infection has cleared. Read on to know more.